Expression Analysis Enters the Agricultural Market with the Purchase of an Illumina Genome Analyzer.

DURHAM, N.C. -- Expression Analysis, Inc., a leading provider of genomic services for clinical trials and research, has entered the Agricultural market and will debut its new services at the upcoming International Plant & Animal Genome Conference in San Diego next week. This announcement comes on the heels of the recent purchase of an Illumina Genome Analyzer.

"We are enthusiastic about the level of client interest in our new plant and animal services, which was a key factor resulting in our decision to add the Genome Analyzer to our laboratory, making Expression Analysis the only Illumina CSPro to offer all four Illumina platforms (Genome Analyzer, iScan, BeadStation, and BeadXpress)," stated Steve McPhail, President & CEO of Expression Analysis. "We have added the Genome Analyzer in response to significant client demand for this technology. As a genomic service provider, responding to client requirements has been a cornerstone to our success. This platform complements our current technologies and will allow us to meet client demands on many fronts; representing another example of our leadership in the industry."

"In addition to owning at least one of every platform marketed by Illumina, we're excited to know that Expression Analysis opted to purchase the Genome Analyzer in order to expand their sequencing services. The Genome Analyzer will continue to allow them to meet client demands," said Tristan Orpin, Senior Vice President of Commercial Operations at Illumina.

Expression Analysis will present their new Agricultural service platform -- "Tools of the Trait[TM]" at the upcoming PAG Conference, booth 517. The company intends to show researchers how they can push the limits of their biological research and accelerate their discoveries.

About Expression Analysis, Inc.

Expertise Beyond Expression -- Providing whole genome to focused set gene expression and genotyping assays, along with sequencing services using Affymetrix, Helicos, Illumina and Applied Biosystems. A leading provider of genomic services in clinical trials and research, offering solutions for various types of specimens as well as nucleic acid isolation and bioinformatic services. The company's quality system follows CLSI guidelines and their CLIA-registered lab supports GLP compliance.